Stock NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Navidea Biopharmaceuticals, Inc.

Equities

NAVB

US63937X2027

Market Closed - OTC Markets
Other stock markets
 11:45:48 2024-05-20 am EDT 		5-day change 1st Jan Change
0.03 USD +15.38% Intraday chart for Navidea Biopharmaceuticals, Inc. 0.00% -45.65%
2023 Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding CI
2023 Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NAVIDEA BIOPHARMACEUTICALS, INC. Stock Navidea Biopharmaceuticals, Inc.
 3M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 55.07B -
LONZA GROUP AG Stock Lonza Group AG
 40.22B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.79B
CELLTRION, INC. Stock Celltrion, Inc.
 28.17B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.28B
  1. Stock Market
  2. Equities
  3. NAVB Stock
  4. Charts Navidea Biopharmaceuticals, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW